Search Results

Containing any of the words

Only of the type

A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06687234 AS ADD-ON THERAPY TO INFLIXIMAB IN ACTIVE ULCERATIVE COLITIS SUBJECTS WHO ARE NOT IN REMISSION (BUILD UC) Drug Clinical Trial

The "SFDA" Warns Consumers not to use "AGIVA BEARD OIL MOUSTACHE 02", as it contains a High Concentration of prohibited Substance Warnings

A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 Drug Clinical Trial

A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease (EASi-PROTKT™) Drug Clinical Trial

A FARAPULSE Pulsed Field Ablation ProspectiVE RegiStry in REal Life Utilization (PF115),Sub-Study: FARAWAY: The FARAPULSE Workflow Assessment Registry (PF117) Clinical Trial

Saudi Food and Drug Authority warns that an important safety information regarding specific models of the SV0.5 FOLFusor and SV 0.5 lnfusor Elastomeric Infusion Pumps, has been issued Warnings

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination with Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer. Drug Clinical Trial

A Global, Phase 1/2, Open-label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants with Propionic Acidemia Drug Clinical Trial

"CAIN457A3404-REALIAA non-interventional, prospective 12-months study to characterize the REAL-life effectiveness and treatment patterns of SecukInumab and current standard of care inpatient with chronic plaque psoriAsis eligible for systemic treatment in the Asia-Pacific and Middle East regions" Drug Clinical Trial

(SG-2003-208-H) COVID-19 - Requests for information regarding the off-label use of GE Healthcare anesthesia devices for ICU ventilation Medical Report